References
- Hueso M, Bover J, Serón D, Gil-Vernet S, Rufi G, Alsina J, et al. The renal transplant patient with visceral leishmaniasis who could not tolerate meglumine antimoniate–cure with ketoconazole and allopurinol. Nephrol Dial Transplant 1999; 14: 2941–3
- Torrus D, Boix V, Massa B, Portilla J, Perez-Mateo M. Fluconazole plus allopurinol in treatment of visceral leishmaniasis. J Antimicrob Chemother 1996; 37: 1042–3
- Peces R, de la Torre M, Alcazar R. Visceral leishmaniasis and renal tuberculosis in a patient on maintenance haemodialysis. Nephrol Dial Transplant 1996; 11: 707–8
- Esteban RJ, Bravo JA, Osuna A, Asensio C. Early antimoniate poisoning in a non-fatal visceral leishmaniasis kidney transplant recipient with renal failure. Nephrol Dial Transplant 1996; 11: 1898
- Gonzalez-Anglada MI, Pena JM, Barbado FJ, Gonzalez JJ, Redondo C, Galera C, et al. Two cases of laryngeal leishmaniasis in patients infected with HIV. Eur J Clin Microbiol Infect Dis 1994; 13: 509–11
- Coppola F, Recchia S, Ferrari A, Del Sedime L. Visceral leishmaniasis in AIDS with gastric involvement. Gastrointest Endosc 1992; 38: 76–8
- Wali JP, Aggarwal P, Gupta U, Saluja S, Singh S. Ketoconazole in treatment of visceral leishmaniasis. Lancet 1990; 336: 810–1
- Sundar S, Singh VP, Agrawal NK, Gibbs DL, Murray HW. Treatment of kala-azar with oral fluconazole. Lancet 1996; 348: 614
- Alrajhi AA, Ibrahim EA, De Vol EB, Khairat M, Faris RM, Maguire JH. Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. N Engl J Med 2002; 346: 891–5.10
- Laguna F, Adrados M, Alvar J, Soriano V, Valencia ME, Moreno V, et al. Visceral leishmaniasis in patients with the human immunodeficiency virus. Eur J Microbiol Infect Dis 1997; 16: 898–903